Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
5,980.00    -35.00 (-0.58%)
Bid:
5,980.00
Ask:
5,985.00
Spread: 5.00 (0.084%)
Market Cap: £5.11b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 38.5b - DCC PLC

5 May 2026 07:00

RNS Number : 9020C
GoldmanSachs International
05 May 2026
 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

DCC PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.25 ordinary shares

Date of dealing

01 May 2026

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

201,341

(0.23)

84,024

(0.09)

(2) Derivatives (other than options)

0

(0.00)

0

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

201,341

(0.23)

84,024

(0.09)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

3. DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Sale (Borrow Partial Return)

15,300

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

(d) Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

04 May 2026

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

KOHLBERG KRAVIS ROBERTS & CO. L. P.

Nature of connection (Note 9)

Advisor to Offeror

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPEADSLEANKEFA
Date   Source Headline
3rd Feb 202211:54 amRNSDCC Technology Presentation and Webcast
15th Dec 20217:00 amRNSDCC Management Presentation
15th Dec 20217:00 amRNSDCC plc acquires Almo Corporation
30th Nov 20214:31 pmRNSTotal Voting Rights
26th Nov 20217:15 amRNSDirector Declaration
15th Nov 20214:25 pmRNSDirector/PDMR Shareholding
11th Nov 20214:58 pmRNSDirector/PDMR Shareholding
11th Nov 202111:25 amRNSDirector/PDMR Shareholding
9th Nov 202110:01 amRNSUpdate on Timing of Interim Results Announcement
9th Nov 20217:00 amRNSBoard Changes
9th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
28th Sep 20217:00 amRNSDCC Healthcare Event
14th Sep 20212:33 pmRNSDCC Healthcare Event
16th Jul 20212:17 pmRNSResult of AGM
16th Jul 20217:00 amRNSBoard Changes
16th Jul 20217:00 amRNSInterim Management Statement
13th Jul 20217:10 amRNS2021 Sustainability Report
7th Jul 20217:01 amRNSMr Cormac McCarthy
17th Jun 202112:34 pmRNS2021 Annual Report, Notice of AGM and Proxy Form
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20215:47 pmRNSDirector/PDMR Shareholding
20th May 20219:45 amRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSAppointment of Chairman Designate & Board Renewal
18th May 20217:00 amRNSResults for the year ended 31 March 2021
23rd Apr 20217:14 amRNSDirector Declaration
1st Apr 20217:13 amRNSDirector Declaration
23rd Mar 20217:06 amRNSDirector Declaration
15th Mar 20217:00 amRNSDCC Healthcare acquires primary care supplier
11th Mar 20219:12 amRNSUpdate on the Migration to Euroclear Bank
26th Feb 202112:26 pmRNSTotal Voting Rights
18th Feb 20212:12 pmRNSDCC Consents to Migration of Ordinary Shares
11th Feb 20215:02 pmRNSDirector/PDMR Shareholding
4th Feb 20215:01 pmRNSDirector/PDMR Shareholding
4th Feb 20211:46 pmRNSResult of EGM
2nd Feb 20217:00 amRNSInterim Management Statement
26th Jan 20217:43 amRNSDirector Declaration
7th Jan 20214:55 pmRNSHolding in Company TR-1
7th Jan 20217:36 amRNSNotice of Extraordinary General Meeting
5th Jan 20217:00 amRNSDCC Significantly Expands Presence - US LPG market
27th Nov 20202:31 pmRNSTotal Voting Rights
18th Nov 202010:05 amRNSEnabling energy transition webcast
17th Nov 202010:16 amRNSDirector/PDMR Shareholding
13th Nov 20203:40 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSResults for the six months ended 30 September 2020
4th Nov 20204:35 pmRNSHolding in Company TR-1
29th Oct 20207:15 amRNSDirector Declaration
23rd Oct 20204:30 pmRNSHolding in Company TR-1
23rd Oct 20209:38 amRNSUpcoming Events
19th Oct 20203:51 pmRNSHolding in Company TR-1
14th Oct 20204:16 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.